These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37487699)

  • 1.
    Maas EJ; Wallingford CK; DeBortoli E; Smit DJ; Betz-Stablein B; Aoude LG; Stark MS; Sturm RA; Soyer HP; McInerney-Leo AM
    J Med Genet; 2023 Sep; 60(9):835-837. PubMed ID: 37487699
    [No Abstract]   [Full Text] [Related]  

  • 2. A Nonsynonymous Variant in the GOLM1 Gene in Cutaneous Malignant Melanoma.
    Teerlink CC; Huff C; Stevens J; Yu Y; Holmen SL; Silvis MR; Trombetti K; Zhao H; Grossman D; Farnham JM; Wen J; Facelli JC; Thomas A; Babst M; Florell SR; Meyer L; Zone JJ; Leachman S; Cannon-Albright LA
    J Natl Cancer Inst; 2018 Dec; 110(12):1380-1385. PubMed ID: 29659923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 activates the transcription of lncRNA NR2F1-AS1 to promote the progression of melanoma via regulating the miR-493-5p/GOLM1 axis.
    Bai M; Wu ZZ; Huang YL; Ke J; Xu Q; Wang X
    J Gene Med; 2021 Jul; 23(7):e3338. PubMed ID: 33822440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells.
    Kong Y; Kumar SM; Xu X
    Arch Pathol Lab Med; 2010 Dec; 134(12):1740-9. PubMed ID: 21128770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unfolding the mutational landscape of human melanoma.
    Davar D; Lin Y; Kirkwood JM
    J Invest Dermatol; 2015 Mar; 135(3):659-662. PubMed ID: 25666674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetics of melanoma.
    Bishop JN; Harland M; Bishop DT
    Br J Hosp Med (Lond); 2006 Jun; 67(6):299-304. PubMed ID: 16821732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics-based analysis reveals elevated MFSD12 as a key promoter of cell proliferation and a potential therapeutic target in melanoma.
    Wei CY; Zhu MX; Lu NH; Peng R; Yang X; Zhang PF; Wang L; Gu JY
    Oncogene; 2019 Mar; 38(11):1876-1891. PubMed ID: 30385854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative genetic analysis suggests that skin color modifies the genetic architecture of melanoma.
    Hulur I; Skol AD; Gamazon ER; Cox NJ; Onel K
    PLoS One; 2017; 12(10):e0185730. PubMed ID: 28973033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A report of malignant melanoma of the skin in sisters.
    MOSCHELLA SL
    Arch Dermatol; 1961 Dec; 84():1024-5. PubMed ID: 14476423
    [No Abstract]   [Full Text] [Related]  

  • 10. Cutaneous melanoma susceptibility and progression genes.
    de Snoo FA; Hayward NK
    Cancer Lett; 2005 Dec; 230(2):153-86. PubMed ID: 16297704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of familial atypical multiple mole-melanoma (FAMMM) syndrome in The Netherlands: how far have we come?
    Gruis NA; Van der Velden PA; Bergman W; Frants RR
    Bull Cancer; 1998 Jul; 85(7):627-30. PubMed ID: 9752270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of cutaneous melanoma.
    Meyer LJ; Zone JH
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):112S-116S. PubMed ID: 7963671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma susceptibility genes.
    Newton-Bishop J; Gruis N
    Melanoma Res; 2010 Jun; 20(3):161-2. PubMed ID: 20442621
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetics of melanoma susceptibility.
    Ghiorzo P; Scarrà GB
    Forum (Genova); 2003; 13(2):114-22; quiz 187. PubMed ID: 14732879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Levels of Genetic Heterogeneity in Matched Lymph Node Metastases from Patients with Melanoma.
    Casula M; Colombino M; Manca A; Caracò C; Botti G; Ascierto PA; Lissia A; Cossu A; Palmieri G;
    J Invest Dermatol; 2016 Sep; 136(9):1917-1920. PubMed ID: 27265006
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recurrent somatic activating RAC1 mutations in melanoma].
    Dereure O
    Ann Dermatol Venereol; 2012 Nov; 139(11):785-6. PubMed ID: 23199784
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeting GOLM1 by microRNA-200a in melanoma suppresses cell proliferation, invasion and migration via regulating PI3K/Akt signaling pathway and epithelial-mesenchymal transition.
    Chen WY; Xu YY; Zhang XY
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6997-7007. PubMed ID: 31486500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of melanoma progression: the rise and fall of cell senescence.
    Bennett DC
    Pigment Cell Melanoma Res; 2016 Mar; 29(2):122-40. PubMed ID: 26386262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Genetics and Epigenetics in Mucosal, Uveal, and Cutaneous Melanomagenesis.
    Venza M; Visalli M; Beninati C; Biondo C; Teti D; Venza I
    Anticancer Agents Med Chem; 2016; 16(5):528-38. PubMed ID: 26234362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetics of susceptibility to cutaneous melanoma.
    Newton Bishop JA; Bishop DT
    Drugs Today (Barc); 2005 Mar; 41(3):193-203. PubMed ID: 15883616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.